Skip to main content
Erschienen in: Journal of Gastrointestinal Surgery 5/2013

01.05.2013 | Original Article

Comparison of the Sixth and Seventh Editions of the AJCC TNM Classification for Gallbladder Cancer

verfasst von: Tak Geun Oh, Moon Jae Chung, Seungmin Bang, Seung Woo Park, Jae Bok Chung, Si Young Song, Gi Hong Choi, Kyung Sik Kim, Woo Jung Lee, Jeong Youp Park

Erschienen in: Journal of Gastrointestinal Surgery | Ausgabe 5/2013

Einloggen, um Zugang zu erhalten

Abstract

Background

This study aimed to compare the seventh edition of the tumor node metastasis (TNM) staging system to the sixth edition to validate its usefulness in predicting prognosis for gallbladder cancer.

Methods

Gallbladder cancer patients were staged according to both the sixth and seventh editions of the American Joint Committee on Cancer (AJCC) staging system.

Results

A total of 142 patients underwent cholecystectomy for gallbladder cancer. According to the seventh edition, the survival time of N1 and N2 was different (P = 0.006), and the survival difference between N0 and N1 became significant after excluding cases with no lymph node dissection (P = 0.035). The −2 log likelihoods of the sixth and seventh edition TNM stages were 216.282 and 217.460, respectively, suggesting non-superiority of the seventh edition. Excluding cases with no lymph node dissection resulted in a lower −2 log likelihood score for both editions (sixth, 157.002; seventh, 158.758).

Conclusions

Sufficient lymph node dissection allows better prognostic stratification by application of the AJCC staging system. Even though the new N stage of the seventh edition showed some improvement in predicting prognosis, the overall performance of the seventh edition was not much better than the sixth. Further improvement is needed in the gallbladder cancer staging system.
Literatur
1.
2.
Zurück zum Zitat Witjes CD, van den Akker SA, Visser O, et al. Gallbladder cancer in the Netherlands: incidence, treatment and survival patterns since 1989. Dig Surg 2012;29(2):92–98.PubMedCrossRef Witjes CD, van den Akker SA, Visser O, et al. Gallbladder cancer in the Netherlands: incidence, treatment and survival patterns since 1989. Dig Surg 2012;29(2):92–98.PubMedCrossRef
3.
Zurück zum Zitat Kiran RP, Pokala N, Dudrick SJ. Incidence pattern and survival for gallbladder cancer over three decades—an analysis of 10301 patients. Ann Surg Oncol 2007;14(2):827–832.PubMedCrossRef Kiran RP, Pokala N, Dudrick SJ. Incidence pattern and survival for gallbladder cancer over three decades—an analysis of 10301 patients. Ann Surg Oncol 2007;14(2):827–832.PubMedCrossRef
4.
Zurück zum Zitat Ito H, Ito K, D'Angelica M, et al. Accurate staging for gallbladder cancer: implications for surgical therapy and pathological assessment. Ann Surg 2011;254(2):320–325.PubMedCrossRef Ito H, Ito K, D'Angelica M, et al. Accurate staging for gallbladder cancer: implications for surgical therapy and pathological assessment. Ann Surg 2011;254(2):320–325.PubMedCrossRef
5.
Zurück zum Zitat Greene FL, American Joint Committee on Cancer, American Cancer Society. AJCC cancer staging handbook: from the AJCC cancer staging manual. 6th ed. New York: Springer, 2002. Greene FL, American Joint Committee on Cancer, American Cancer Society. AJCC cancer staging handbook: from the AJCC cancer staging manual. 6th ed. New York: Springer, 2002.
6.
Zurück zum Zitat Tsukada K, Hatakeyama K, Kurosaki I, et al. Outcome of radical surgery for carcinoma of the gallbladder according to the TNM stage. Surgery 1996;120(5):816–821.PubMedCrossRef Tsukada K, Hatakeyama K, Kurosaki I, et al. Outcome of radical surgery for carcinoma of the gallbladder according to the TNM stage. Surgery 1996;120(5):816–821.PubMedCrossRef
7.
Zurück zum Zitat Ito H, Matros E, Brooks DC, et al. Treatment outcomes associated with surgery for gallbladder cancer: a 20-year experience. J Gastrointest Surg 2004;8(2):183–190.PubMedCrossRef Ito H, Matros E, Brooks DC, et al. Treatment outcomes associated with surgery for gallbladder cancer: a 20-year experience. J Gastrointest Surg 2004;8(2):183–190.PubMedCrossRef
8.
Zurück zum Zitat Edge SB, American Joint Committee on Cancer, American Cancer Society. AJCC cancer staging handbook: from the AJCC cancer staging manual. 7th ed. New York: Springer, 2010. Edge SB, American Joint Committee on Cancer, American Cancer Society. AJCC cancer staging handbook: from the AJCC cancer staging manual. 7th ed. New York: Springer, 2010.
9.
Zurück zum Zitat Lendoire JC, Gil L, Duek F, et al. Relevance of residual disease after liver resection for incidental gallbladder cancer. HPB (Oxford) 2012;14(8):548–553.CrossRef Lendoire JC, Gil L, Duek F, et al. Relevance of residual disease after liver resection for incidental gallbladder cancer. HPB (Oxford) 2012;14(8):548–553.CrossRef
10.
Zurück zum Zitat Duffy A, Capanu M, Abou-Alfa GK, et al. Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC). J Surg Oncol 2008;98(7):485–489.PubMedCrossRef Duffy A, Capanu M, Abou-Alfa GK, et al. Gallbladder cancer (GBC): 10-year experience at Memorial Sloan-Kettering Cancer Centre (MSKCC). J Surg Oncol 2008;98(7):485–489.PubMedCrossRef
11.
Zurück zum Zitat Kang CM, Choi GH, Park SH, et al. Laparoscopic cholecystectomy only could be an appropriate treatment for selected clinical R0 gallbladder carcinoma. Surg Endosc 2007;21(9):1582–1587.PubMedCrossRef Kang CM, Choi GH, Park SH, et al. Laparoscopic cholecystectomy only could be an appropriate treatment for selected clinical R0 gallbladder carcinoma. Surg Endosc 2007;21(9):1582–1587.PubMedCrossRef
12.
Zurück zum Zitat Dixon E, Vollmer CM, Jr., Sahajpal A, et al. An aggressive surgical approach leads to improved survival in patients with gallbladder cancer: a 12-year study at a North American Center. Ann Surg 2005;241(3):385–394.PubMedCrossRef Dixon E, Vollmer CM, Jr., Sahajpal A, et al. An aggressive surgical approach leads to improved survival in patients with gallbladder cancer: a 12-year study at a North American Center. Ann Surg 2005;241(3):385–394.PubMedCrossRef
13.
Zurück zum Zitat Choi SB, Han HJ, Kim CY, et al. Fourteen year surgical experience of gallbladder cancer: validity of curative resection affecting survival. Hepatogastroenterology 2012;59(113):36–41.PubMed Choi SB, Han HJ, Kim CY, et al. Fourteen year surgical experience of gallbladder cancer: validity of curative resection affecting survival. Hepatogastroenterology 2012;59(113):36–41.PubMed
14.
Zurück zum Zitat Cziupka K, Partecke LI, Mirow L, et al. Outcomes and prognostic factors in gallbladder cancer: a single-centre experience. Langenbecks Arch Surg 2012;397(6):899–907.PubMedCrossRef Cziupka K, Partecke LI, Mirow L, et al. Outcomes and prognostic factors in gallbladder cancer: a single-centre experience. Langenbecks Arch Surg 2012;397(6):899–907.PubMedCrossRef
15.
Zurück zum Zitat Jensen EH, Abraham A, Jarosek S, et al. Lymph node evaluation is associated with improved survival after surgery for early stage gallbladder cancer. Surgery 2009;146(4):706–711; discussion 711–703.PubMedCrossRef Jensen EH, Abraham A, Jarosek S, et al. Lymph node evaluation is associated with improved survival after surgery for early stage gallbladder cancer. Surgery 2009;146(4):706–711; discussion 711–703.PubMedCrossRef
16.
Zurück zum Zitat Shirai Y, Sakata J, Wakai T, Hatakeyama K. Full-thickness cholecystectomy with limited lymphadenectomy for gallbladder cancer. Hepatogastroenterology 2012;59(117):1338–1340.PubMed Shirai Y, Sakata J, Wakai T, Hatakeyama K. Full-thickness cholecystectomy with limited lymphadenectomy for gallbladder cancer. Hepatogastroenterology 2012;59(117):1338–1340.PubMed
17.
Zurück zum Zitat Lee SE, Jang JY, Lim CS, Kang MJ, Kim SW. Systematic review on the surgical treatment for T1 gallbladder cancer. World J Gastroenterol 2011;17(2):174–180.PubMedCrossRef Lee SE, Jang JY, Lim CS, Kang MJ, Kim SW. Systematic review on the surgical treatment for T1 gallbladder cancer. World J Gastroenterol 2011;17(2):174–180.PubMedCrossRef
18.
Zurück zum Zitat Pawlik TM, Gleisner AL, Vigano L, et al. Incidence of finding residual disease for incidental gallbladder carcinoma: implications for re-resection. J Gastrointest Surg 2007;11(11):1478–1486; discussion 1486–1477.PubMedCrossRef Pawlik TM, Gleisner AL, Vigano L, et al. Incidence of finding residual disease for incidental gallbladder carcinoma: implications for re-resection. J Gastrointest Surg 2007;11(11):1478–1486; discussion 1486–1477.PubMedCrossRef
19.
Zurück zum Zitat Kang CM, Lee WJ, Choi GH, et al. Does "clinical" R0 have validity in the choice of simple cholecystectomy for gallbladder carcinoma? J Gastrointest Surg 2007;11(10):1309–1316.PubMedCrossRef Kang CM, Lee WJ, Choi GH, et al. Does "clinical" R0 have validity in the choice of simple cholecystectomy for gallbladder carcinoma? J Gastrointest Surg 2007;11(10):1309–1316.PubMedCrossRef
20.
Zurück zum Zitat Nanashima A, Tobinaga S, Abo T, et al. Evaluation of surgical resection for gallbladder carcinoma at a Japanese cancer institute. Hepatogastroenterology 2012;59(118):1717–1721.PubMed Nanashima A, Tobinaga S, Abo T, et al. Evaluation of surgical resection for gallbladder carcinoma at a Japanese cancer institute. Hepatogastroenterology 2012;59(118):1717–1721.PubMed
21.
Zurück zum Zitat Jensen EH, Abraham A, Habermann EB, et al. A critical analysis of the surgical management of early-stage gallbladder cancer in the United States. J Gastrointest Surg 2009;13(4):722–727.PubMedCrossRef Jensen EH, Abraham A, Habermann EB, et al. A critical analysis of the surgical management of early-stage gallbladder cancer in the United States. J Gastrointest Surg 2009;13(4):722–727.PubMedCrossRef
22.
Zurück zum Zitat Fetzner UK, Holscher AH, Stippel DL. Regional lymphadenectomy strongly recommended in T1b gallbladder cancer. World J Gastroenterol 2011;17(38):4347–4348.PubMedCrossRef Fetzner UK, Holscher AH, Stippel DL. Regional lymphadenectomy strongly recommended in T1b gallbladder cancer. World J Gastroenterol 2011;17(38):4347–4348.PubMedCrossRef
23.
Zurück zum Zitat Shirai Y, Wakai T, Sakata J, Hatakeyama K. Regional lymphadenectomy for gallbladder cancer: Rational extent, technical details, and patient outcomes. World J Gastroenterol 2012;18(22):2775–2783.PubMedCrossRef Shirai Y, Wakai T, Sakata J, Hatakeyama K. Regional lymphadenectomy for gallbladder cancer: Rational extent, technical details, and patient outcomes. World J Gastroenterol 2012;18(22):2775–2783.PubMedCrossRef
24.
Zurück zum Zitat Sakata J, Shirai Y, Wakai T, Ajioka Y, Hatakeyama K. Number of positive lymph nodes independently determines the prognosis after resection in patients with gallbladder carcinoma. Ann Surg Oncol 2010;17(7):1831–1840.PubMedCrossRef Sakata J, Shirai Y, Wakai T, Ajioka Y, Hatakeyama K. Number of positive lymph nodes independently determines the prognosis after resection in patients with gallbladder carcinoma. Ann Surg Oncol 2010;17(7):1831–1840.PubMedCrossRef
25.
Zurück zum Zitat Negi SS, Singh A, Chaudhary A. Lymph nodal involvement as prognostic factor in gallbladder cancer: location, count or ratio? J Gastrointest Surg 2011;15(6):1017–1025.PubMedCrossRef Negi SS, Singh A, Chaudhary A. Lymph nodal involvement as prognostic factor in gallbladder cancer: location, count or ratio? J Gastrointest Surg 2011;15(6):1017–1025.PubMedCrossRef
26.
Zurück zum Zitat Shirai Y, Sakata J, Wakai T, Ohashi T, Ajioka Y, Hatakeyama K. Assessment of lymph node status in gallbladder cancer: location, number, or ratio of positive nodes. World J Surg Oncol 2012;10(1):87.PubMedCrossRef Shirai Y, Sakata J, Wakai T, Ohashi T, Ajioka Y, Hatakeyama K. Assessment of lymph node status in gallbladder cancer: location, number, or ratio of positive nodes. World J Surg Oncol 2012;10(1):87.PubMedCrossRef
27.
Zurück zum Zitat De Jong MC, Nathan H, Sotiropoulos GC, et al. Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment. J Clin Oncol 2011;29(23):3140–3145PubMedCrossRef De Jong MC, Nathan H, Sotiropoulos GC, et al. Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment. J Clin Oncol 2011;29(23):3140–3145PubMedCrossRef
Metadaten
Titel
Comparison of the Sixth and Seventh Editions of the AJCC TNM Classification for Gallbladder Cancer
verfasst von
Tak Geun Oh
Moon Jae Chung
Seungmin Bang
Seung Woo Park
Jae Bok Chung
Si Young Song
Gi Hong Choi
Kyung Sik Kim
Woo Jung Lee
Jeong Youp Park
Publikationsdatum
01.05.2013
Verlag
Springer-Verlag
Erschienen in
Journal of Gastrointestinal Surgery / Ausgabe 5/2013
Print ISSN: 1091-255X
Elektronische ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-012-2134-9

Weitere Artikel der Ausgabe 5/2013

Journal of Gastrointestinal Surgery 5/2013 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.